نتایج جستجو برای: alk kinase

تعداد نتایج: 231548  

Journal: :Blood 2004
Ting-Lei Gu Zuzana Tothova Blanca Scheijen James D Griffin D Gary Gilliland David W Sternberg

Between 30% and 50% of patients with advanced-stage anaplastic large-cell lymphoma (ALCL) harbor the balanced chromosomal rearrangement t(2;5)(p23;q35), which results in the generation of the fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK). To further study survival signaling by NPMALK, we generated Ba/F3 cell lines with either inducible or constitutive expression of NPM-ALK a...

Journal: :EMBO reports 2003
Christina E Lorén Camilla Englund Caroline Grabbe Bengt Hallberg Tony Hunter Ruth H Palmer

The Drosophila melanogaster gene Anaplastic lymphoma kinase (Alk) is homologous to mammalian Alk, which encodes a member of the Alk/Ltk family of receptor tyrosine kinases (RTKs). In humans, the t(2;5) translocation, which involves the ALK locus, produces an active form of ALK, which is the causative agent in non-Hodgkin's lymphoma. The physiological function of the Alk RTK, however, is unknown...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Jussi P Koivunen Craig Mermel Kreshnik Zejnullahu Carly Murphy Eugene Lifshits Alison J Holmes Hwan Geun Choi Jhingook Kim Derek Chiang Roman Thomas Jinseon Lee William G Richards David J Sugarbaker Christopher Ducko Neal Lindeman J Paul Marcoux Jeffrey A Engelman Nathanael S Gray Charles Lee Matthew Meyerson Pasi A Jänne

PURPOSE The EML4-ALK fusion gene has been detected in approximately 7% of Japanese non-small cell lung cancers (NSCLC). We determined the frequency of EML4-ALK in Caucasian NSCLC and in NSCLC cell lines. We also determined whether TAE684, a specific ALK kinase inhibitor, would inhibit the growth of EML4-ALK-containing cell lines in vitro and in vivo. EXPERIMENTAL DESIGN We screened 305 primar...

Journal: :Frontiers in bioscience 2015
Marco Pizzi Marcello Gaudiano Maria Todaro Giorgio Inghirami

The discovery of Anaplastic Lymphoma Kinase (ALK) by Stephan Morris and colleagues twenty years ago has led to an unprecedented opportunity and provided the basis for a novel and clinically powerful stratification of human cancers. The molecular and biological characterization of ALK and the recognition of alternative mechanisms of activation of the tyrosine kinase receptors have then set the b...

Journal: :Cancer research 2008
Ultan McDermott A John Iafrate Nathanael S Gray Toshi Shioda Marie Classon Shyamala Maheswaran Wenjun Zhou Hwan Geun Choi Shannon L Smith Lori Dowell Lindsey E Ulkus Georgiana Kuhlmann Patricia Greninger James G Christensen Daniel A Haber Jeffrey Settleman

Selective kinase inhibitors have had a substantial impact on the field of medical oncology. Whereas these agents can elicit dramatic clinical responses in some settings, their activity is generally limited to a subset of treated patients whose tumor cells harbor a specific genetic lesion. We have established an automated platform for examining the sensitivity to various molecularly targeted inh...

Journal: :Chemical communications 2015
Wei Cui Laurie L Parker

A novel time-resolved luminescence biosensor assay for anaplastic lymphoma kinase (ALK) was developed. We used a straightforward strategy to modify a known ALK substrate into a peptide biosensor that can accommodate terbium luminescence sensitization upon its phosphorylation by ALK. Since this strategy is generalizable, this high-throughput screening compatible assay serves as an example for de...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2008
Manabu Soda Shuji Takada Kengo Takeuchi Young Lim Choi Munehiro Enomoto Toshihide Ueno Hidenori Haruta Toru Hamada Yoshihiro Yamashita Yuichi Ishikawa Yukihiko Sugiyama Hiroyuki Mano

EML4-ALK is a fusion-type protein tyrosine kinase that is generated in human non-small-cell lung cancer (NSCLC) as a result of a recurrent chromosome inversion, inv (2)(p21p23). Although mouse 3T3 fibroblasts expressing human EML4-ALK form transformed foci in culture and s.c. tumors in nude mice, it has remained unclear whether this fusion protein plays an essential role in the carcinogenesis o...

Journal: :Cancer research 2011
Tommy Martinsson Therese Eriksson Jonas Abrahamsson Helena Caren Magnus Hansson Per Kogner Sattu Kamaraj Christina Schönherr Joel Weinmar Kristina Ruuth Ruth H Palmer Bengt Hallberg

Mutations in the kinase domain of the ALK kinase have emerged recently as important players in the genetics of the childhood tumor neuroblastoma. Here, we report the appearance of a novel ALK mutation in neuroblastoma, correlating with aggressive tumor behavior. Analyses of genomic DNA from biopsy samples initially showed ALK sequence to be wild type. However, during disease progression, mutati...

Journal: :Cancer research 2009
Lorena Passoni Luca Longo Paola Collini Addolorata Maria Luce Coluccia Fabio Bozzi Marta Podda Andrea Gregorio Claudio Gambini Alberto Garaventa Vito Pistoia Federica Del Grosso Gian Paolo Tonini Mangeng Cheng Carlo Gambacorti-Passerini Andrea Anichini Franca Fossati-Bellani Massimo Di Nicola Roberto Luksch

Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase predominantly expressed in the developing nervous system. Recently, mutated ALK has been identified as a major oncogene associated with familial and sporadic neuroblastomas (NBL). Yet, a direct correlation between endogenous expression level of the ALK protein, oncogenic potential, and clinical outcome has not been established. We i...

2015
Géraldine Mitou Julie Frentzel Aurore Desquesnes Sophie Le Gonidec Talal AlSaati Isabelle Beau Laurence Lamant Fabienne Meggetto Estelle Espinos Patrice Codogno Pierre Brousset Sylvie Giuriato

Anaplastic Lymphoma Kinase-positive Anaplastic Large Cell Lymphomas (ALK+ ALCL) occur predominantly in children and young adults. Their treatment, based on aggressive chemotherapy, is not optimal since ALCL patients can still expect a 30% 2-year relapse rate. Tumor relapses are very aggressive and their underlying mechanisms are unknown. Crizotinib is the most advanced ALK tyrosine kinase inhib...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید